GAMMA Investing’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Buy
6,705
+1,320
+25% +$51.6K 0.01% 858
2026
Q1
$190K Buy
5,385
+22
+0.4% +$682 0.01% 1157
2025
Q4
$150K Buy
5,363
+969
+22% +$29K 0.01% 1253
2025
Q3
$132K Sell
4,394
-569
-11% -$16K 0.01% 1274
2025
Q2
$142K Sell
4,963
-433
-8% -$12.9K 0.01% 1158
2025
Q1
$178K Buy
5,396
+1,305
+32% +$42.6K 0.01% 828
2024
Q4
$118K Sell
4,091
-113
-3% -$3.25K 0.01% 990
2024
Q3
$118K Buy
4,204
+1,917
+84% +$51.1K 0.01% 894
2024
Q2
$55.1K Buy
2,287
+703
+44% +$17.2K 0.01% 1121
2024
Q1
$42.9K Buy
1,584
+280
+21% +$7.95K 0.01% 1144
2023
Q4
$35.3K Buy
+1,304
New +$33.9K 0.01% 1120

Other funds holding ALKS

GAMMA Investing's ALKS Position: Q2 2026 in Review

GAMMA Investing increased its Alkermes (ALKS) stake by 25% in Q2 2026, buying an estimated $51.6K and bringing the position to 6,705 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #858.

GAMMA Investing first reported a position in ALKS in Q4 2023 and has held it in 11 quarters since. 54 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • GAMMA Investing held 6,705 shares of Alkermes worth $351K as of Q2 2026.
  • GAMMA Investing bought 1,320 Alkermes shares in Q2 2026, an estimated $51.6K.
  • Alkermes made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #858 holding.
  • GAMMA Investing first reported a position in Alkermes in Q4 2023 and has held it in 11 quarters since.
  • 54 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.